Back

The integrated nature of cardiorenal metabolic health

19 May 2025 (12:33 - 12:38)
Organised by: Logo
Congress Presentation Part of: Does aldosterone synthase inhibition hold a key to transforming cardiorenal care? Aldosterone Antagonists HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Professor Lars Lund

Karolinska University Hospital, Stockholm (Sweden)

6 More presentations in this session

Presentation thumbnail
Welcome and introductions
Slides
Presentation thumbnail
The role of aldosterone and its part in cardiorenal disease
Doctor M. Costanzo (Naperville, US)
Slides
Presentation thumbnail
Insights from the vicadrostat phase 2 study and implications for further clinical development
Doctor R. Mentz (Durham, US)
Slides
Presentation thumbnail
Aldosterone synthase inhibition and the future CRM treatment landscape
Professor J. Butler (Dallas, US)
Slides
Presentation thumbnail
Outlook, panel discussion and Q&A
Slides

Access the full session

Session thumbnail
Does aldosterone synthase inhibition hold a key to transforming cardiorenal care?
Video

The Event

Event poster

Heart Failure 2025

19 May 2025 12:33 CET
You may be interested in
thumbnail
Congress Session
Cardio-renal-metabolic conundrum in heart failure
19 May 2025
thumbnail
Congress Session
Obesity as a cardiovascular disease: integrated management
3 April 2025
thumbnail
Congress Session
Metabolism and cardiovascular diseases: completely inseparable
28 August 2023
thumbnail
Congress Session
Late-breaking science in acute heart failure
19 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources